Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
2.810
-0.120 (-4.10%)
At close: May 18, 2026, 4:00 PM EDT
2.874
+0.064 (2.27%)
Pre-market: May 19, 2026, 8:40 AM EDT
Prime Medicine Employees
Prime Medicine had 146 employees as of December 31, 2025. The number of employees decreased by 68 or -31.78% compared to the previous year.
Employees
146
Change (1Y)
-68
Growth (1Y)
-31.78%
Revenue / Employee
$27,630
Profits / Employee
-$1,358,726
Market Cap
507.54M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 146 | -68 | -31.78% |
| Dec 31, 2024 | 214 | -20 | -8.55% |
| Dec 31, 2023 | 234 | 59 | 33.71% |
| Dec 31, 2022 | 175 | 74 | 73.27% |
| Sep 30, 2022 | 150 | 86 | 134.38% |
| Jun 30, 2022 | 137 | 73 | 114.06% |
| Mar 31, 2022 | 101 | - | - |
| Sep 30, 2021 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Rigel Pharmaceuticals | 174 |
| Cabaletta Bio | 156 |
| Adlai Nortye | 109 |
| Prothena Corporation | 67 |
| Tectonic Therapeutic | 60 |
| AgomAb Therapeutics NV | 58 |
| Contineum Therapeutics | 51 |
PRME News
- 11 days ago - Prime Medicine reports Q1 EPS (28c), consensus (25c) - TheFly
- 12 days ago - Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 12 days ago - Prime Medicine Quarterly report: Q1 2026 - Filings
- 12 days ago - Prime Medicine Earnings release: Q1 2026 - Filings
- 12 days ago - Prime Medicine management to meet with Oppenheimer - TheFly
- 26 days ago - Prime Medicine Proxy statement: Proxy filing - Filings
- 26 days ago - Prime Medicine Proxy statement: Proxy filing - Filings
- 4 weeks ago - Prime Medicine appoints Makhni as Chief Financial Officer - TheFly